Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer
Ganji Purnachandra Nagaraju(University of Alabama at Birmingham Hospital), Bassel F. El‐Rayes(University of Alabama at Birmingham)
Cited by 64
Related Papers
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914